Ovarian cancer relapses may be effectively monitored and, possibly, detected early by analyzing patients’ DNA in blood samples, Mayo Clinic researchers report in the study, “Quantification of Somatic Chromosomal Rearrangements in Circulating Cell-Free DNA from Ovarian Cancers,” published in the ... Read more